Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
...
Health Technology » Pharmaceuticals Major
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| JNJ | Johnson & Johnson | -0.21% | 177.76 | 0.7% | $1347.68m | |
| MRK | Merck & Co., Inc. | 0.69% | 93.28 | 0.7% | $1220.32m | |
| PFE | Pfizer Inc. | 0.90% | 52.11 | 0.9% | $1105.14m | |
| LLY | Eli Lilly & Co. | 0.46% | 328.68 | 1.1% | $1030.86m | |
| BMY | Bristol-Myers Squibb Co. | 0.19% | 76.11 | 1.0% | $993.47m | |
| ABBV | AbbVie, Inc. | -1.32% | 151.90 | 1.9% | $947.56m | |
| AZN | AstraZeneca Plc | 0.59% | 65.90 | 1.0% | $473.76m | |
| SGEN | Seagen Inc. | -0.67% | 175.60 | 5.7% | $323.90m | |
| GSK | GSK Plc | -0.66% | 43.02 | 0.2% | $270.63m | |
| TPTX | Turning Point Therapeutics, Inc. | -0.17% | 75.03 | 0.0% | $198.96m | |
| HZNP | Horizon Therapeutics Plc | -0.88% | 82.03 | 5.4% | $172.55m | |
| NVS | Novartis AG | -1.05% | 83.40 | 0.2% | $170.47m | |
| ALNY | Alnylam Pharmaceuticals, Inc. | -0.13% | 150.53 | 8.1% | $150.11m | |
| MRTX | Mirati Therapeutics, Inc. | -1.76% | 70.69 | 1.6% | $148.15m | |
| NVO | Novo Nordisk A/S | -0.73% | 110.43 | 0.1% | $147.29m |
Company Profile
Biohaven Pharmaceutical Holding Co. Ltd. is a clinical-stage biopharmaceutical company, which engages in the research and development of late-stage product candidates targeting neurological diseases, including rare disorders. It focuses on a pipeline of product candidates that represent mechanistic platforms, calcitonin gene-related peptide receptor antagonists, and glutamate modulators. The company was founded in September 2013 and is headquartered in New Haven, CT.